Literature DB >> 2474808

Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat.

C K Svensson1, P W Knowlton.   

Abstract

Interferon and interferon inducers have been found to inhibit cytochrome P-450-dependent metabolism in animals and man. The effect of these agents on the acetylation of drugs has not been previously reported. Since these agents stimulate the reticuloendothelial system, together with the abundance of N-acetyltransferase in the reticuloendothelial system, it was hypothesized that these immunomodulators may affect drug acetylation. To test this hypothesis, the effect of tilorone (a synthetic interferon inducer) on the in vivo acetylation of procainamide was examined in the rat. Pretreatment with tilorone hydrochloride (50 mg/kg) 48 hr prior to the administration of procainamide hydrochloride (50 mg/kg) resulted in a 32% increase in the urinary recovery of N-acetylprocainamide and a 35% increase in the metabolic clearance of procainamide to N-acetylprocainamide. These data indicate that interferon inducers increase the N-acetylation of drugs in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474808     DOI: 10.1023/a:1015964306318

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Depression of oxidative metabolism of aspirin in mice via an interferon-associated mechanism in relation to Reye's syndrome.

Authors:  C T Dolphin; J Caldwell; R L Smith
Journal:  J Pharm Pharmacol       Date:  1987-03       Impact factor: 3.765

Review 2.  The pharmacology and toxicology of the interferons: an overview.

Authors:  G J Mannering; L B Deloria
Journal:  Annu Rev Pharmacol Toxicol       Date:  1986       Impact factor: 13.820

3.  Influence of sex and Freund's adjuvant on liver N-acetyltransferase activity and elimination of sulphadimidine in urine of rats.

Authors:  Z Zídek; M Friebová; I Jankö; J Elis
Journal:  Biochem Pharmacol       Date:  1977-01-01       Impact factor: 5.858

4.  Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation.

Authors:  G Singh; K W Renton; N Stebbing
Journal:  Biochem Biophys Res Commun       Date:  1982-06-30       Impact factor: 3.575

5.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

6.  Effect of the immunomodulator tilorone on antipyrine disposition in the rat.

Authors:  C K Svensson
Journal:  J Pharm Sci       Date:  1986-10       Impact factor: 3.534

7.  Induction of acetylating capacity with complete Freund's adjuvant and hydrocortisone in the rabbit.

Authors:  P du Souich; H Courteau
Journal:  Drug Metab Dispos       Date:  1981 May-Jun       Impact factor: 3.922

8.  Effect of poly rI:rC treatment upon the metabolism of [14C]-paracetamol in the BALB/cJ mouse.

Authors:  C T Dolphin; J Caldwell; R L Smith
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

9.  Induction of sulfamethazine acetylation by hydrocortisone in the rabbit.

Authors:  P T Reeves; R F Minchin; K F Ilett
Journal:  Drug Metab Dispos       Date:  1988 Jan-Feb       Impact factor: 3.922

10.  Depression of cytochrome P-450-dependent drug biotransformation in hepatocytes after the activation of the reticuloendothelial system by dextran sulfate.

Authors:  T C Peterson; K W Renton
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

View more
  4 in total

Review 1.  Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance.

Authors:  G J Sewell
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

2.  Effects of ellagic acid by oral administration on N-acetylation and metabolism of 2-aminofluorene in rat brain tissues.

Authors:  S S Lin; C F Hung; C C Ho; Y H Liu; H C Ho; J G Chung
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

3.  Discovery, synthesis and structure-activity analysis of symmetrical 2,7-disubstituted fluorenones as urea transporter inhibitors.

Authors:  Sujin Lee; Cristina Esteva-Font; Puay-Wah Phuan; Marc O Anderson; A S Verkman
Journal:  Medchemcomm       Date:  2015       Impact factor: 3.597

Review 4.  Role of viral infections in the induction of adverse drug reactions.

Authors:  M Levy
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.